Advanced International Breast Cancer Course

Breast cancer research has been the frontrunner in many fields of cancer research: epidemiology, life-style and genetic risk factors, secondary prevention, conservative surgery, molecular classification, curative adjuvant therapies, neoadjuvant treatments, targeted agents, survival prolongation in advanced stages. Thanks to this knowledge, today many breast cancers can be prevented, most can be diagnosed at early stages and cured and the minority of patients at advanced stages can still enjoy a significant survival with a reasonable quality of life.

As a consequence of these major improvements, the bar of research and clinical excellence for breast cancer has raised even more.

New prognostic and predictive biomarkers are available, need to be validated and to be implemented in trial design and clinical practice. Risk-adapted surgery and radiation therapy allow for less and less invasive procedures. Multiple effective adjuvant therapies in the different molecular breast cancer subtypes, require a more precise definition of risk and predictivity of drug efficacy, to allow for a rational de-escalation or escalation of curative treatments. The impressive advances in the treatment of advanced breast cancers, envisage the possibility of cure with a multimodality approach for some patients and guarantee a prolonged survival for most of them with a rational sequencing of treatments.

The 21st AIBCC in Padova, will allow to sum up the most recent biological and clinical achievements and to allow an open and friendly discussion of clinical cases among key opinion leaders and participants.

Chairpersons: Pierfranco Conte, Aleix Prat

Chairpersons: Bettina Borisch, Fedro Peccatori

Chairpersons: Giuseppe Curigliano, Sibylle Loibl

Chairpersons: Lucia del Mastro, Michelino De Laurentiis

Chairpersons: Alessandra Gennari, Fabio Puglisi

The Scientific Committee will select a young researcher working in Europe ( ≤ 40 years old, medical oncologist, breast surgeon, patologist, radiation oncologist or other breast cancer specialist). Candidates will be asked to submit a publication where they are the lead author, published in 2024–2025, along with a CV.

For application, the candidates have to send their CV and chosen publication 2024-2025, by July 30, 2025 to info.bologna@accmed.org

The winner will be invited to present his study at the AIBCC (with travel and accommodation expenses covered).

Some fellowship (for under 40) will be awarded including registration, 1 hotel night and travel organization. Those interested should send the registration form together with a short CV and a motivation letter within July 30th.
The organizing secretariat will confirm the award of the fellowship within August 5th and proceed with the organization of logistics.

Free admission is available for some people “under 40”. Registration forms will be accepted on a first-come, first-served basis until spaces will be full. The Organization Secretariat will confirm the registration by email.